GL1X · GenesisL1 explorer

MolNFT v1 · #167771 · protein

Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor SGT392

6VUT · N-acetyltransferase eis: “Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor SGT392”. X-ray diffraction, 3 ligands (RN7, NA, SO4), 3 pockets (best druggability 0.77). MolNFT v1 #167771 on GenesisL1…

PDB
6VUT
Type
protein
Length
396 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
N-acetyltransferase eis
EC
2.3.1.-
UniProt
P9WFK7
Ligands
RN7, NA, SO4
Pockets
3 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AN-acetyltransferase eis (EC 2.3.1.-)protein39630% helix, 31% strandP9WFK7

Ligands and binding sites

  • RN7 · 2-[(4-amino-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(morpholin-4-yl) ethyl]acetamide · ligand · chains A
  • NA · Sodium ion · metal · 3 copies · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • PEG · Di(hydroxyethyl)ether · additive · 2 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110510.770.7995RN7, PEG, SO4, NA
2590.310.7613empty
3530.300.7719SO4

Compared structures

  • 6VUT · Crystal structure of Eis from Mycobacterium tuberculosis in complex with inhibitor SGT392 · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WFK7 · AlphaFold monomer V2.0 prediction for N-acetyltransferase eis (P9WFK7) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.